Attached files
| file | filename |
|---|---|
| 8-K - CURRENT REPORT - IMMUCELL CORP /DE/ | f8k030216_immucellcorp.htm |
Exhibit 16.1
March 7, 2016
Securities and Exchange Commission
Washington, D.C. 20549
Commissioners:
We have read ImmuCell Corporation’s statements included under Item 4.01 of its Form 8-K filed on March 7, 2016 and we agree with such statements concerning our firm.
/s/ Baker Newman & Noyes
BAKER NEWMAN & NOYES
LIMITED LIABILITY COMPANY